Comprehensive Lipidemia Panel

The Comprehensive Lipidemia Panel provides a comprehensive analysis of genes associated with a variety of inherited lipidemias. Lipidemias are characterized by abnormal levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and/or triglycerides. Abnormal lipid levels increase the risk for cardiovascular events and can cause additional clinical complications. Early and appropriate medical intervention can reduce the risk of cardiovascular events. At-risk relatives could be identified, and preventive therapy could be initiated. Given the clinical overlap between different lipidemias, comprehensive testing enables a more efficient evaluation of multiple disorders based on a single indication.